BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 922750)

  • 1. Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel.
    Posey LE; Morgan LR
    Cancer Treat Rep; 1977 Nov; 61(8):1453-8. PubMed ID: 922750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
    Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
    Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
    [No Abstract]   [Full Text] [Related]  

  • 3. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
    Togni P; Sessa C; Varini M; Cavalli F
    Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of advanced colorectal cancer with methyl-CCNU plus 5-day 5-fluorouracil infusion.
    Kane RC; Cashdollar MR; Bernath AM
    Cancer Treat Rep; 1978 Oct; 62(10):1521-5. PubMed ID: 709554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of melphalan plus 5-fluorouracil (5-FU) versus methyl-CCNU plus 5-FU in patients with advanced colorectal cancer.
    Berman R; Giles GR; Malhotra A; Bird GG; Gajjar PD; Bunch GA; Hall R
    Cancer Treat Rep; 1978 Mar; 62(3):457-9. PubMed ID: 348316
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study.
    White LA; Perry MC; Kardinal CG; Kennedy BJ; Weiss RB; Carey RW
    Cancer Treat Rep; 1979 Feb; 63(2):215-7. PubMed ID: 445497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
    Cedermark BJ; Didolkar MS; Elias EG
    Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy for advanced colorectal cancer with triazinate, ICRF-159, 5-FU, and methyl-CCNU.
    Vogl SE; Qazi R; Berenzweig M
    Cancer Treat Rep; 1980; 64(10-11):1143-5. PubMed ID: 7459902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU.
    Macdonald JS; Kisner DF; Smythe T; Woolley PV; Smith L; Schein PS
    Cancer Treat Rep; 1976 Nov; 60(11):1597-600. PubMed ID: 1021233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer.
    Buroker T; Wojtaszak B; Dindogru A; DeMattia M; Baker L; Groth C; Vaitkevicius VK
    Cancer Treat Rep; 1978 May; 62(5):689-92. PubMed ID: 350398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.
    Douglass HO; Lavin PT; Moertel CG
    Cancer Treat Rep; 1976 Jun; 60(6):769-80. PubMed ID: 782699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
    Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
    Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of advanced digestive cancer with fluorouracil and methyl-CCNU].
    Fleischer I; Wainstein R; Jovtis S; Colombato LO
    Acta Gastroenterol Latinoam; 1978; 8(3):191-3. PubMed ID: 747086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled study of 5-fluorouracil versus 5-fluorouracil and methyl-CCNU in advanced gastrointestinal adenocarcinoma.
    Abdallah AM; Soukop M; Bell G; Calman KC
    Clin Oncol; 1977 Sep; 3(3):247-57. PubMed ID: 334430
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined actions of 5-fluorouracil and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on human colonic carcinoma cells in vitro.
    Sutton JE; Roos IA; Hillcoat BL
    Cancer Res; 1982 Dec; 42(12):5172-5. PubMed ID: 7139620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Baker LH; Vaitkevicius VK; Gehan E
    Cancer Treat Rep; 1976 Jun; 60(6):733-7. PubMed ID: 954013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of advanced colorectal cancer with a combination of 5-fluorouracil and methyl-CCNU.
    Fischetti MR; Carey RW; Weitzman SA; Kaufman S; Kelley RM; Sohier WD
    Med Pediatr Oncol; 1978; 4(3):277-8. PubMed ID: 683130
    [No Abstract]   [Full Text] [Related]  

  • 18. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764).
    Shaw MT; Bonnet JD; Wilson H; Heilbrun LK
    Cancer Treat Rep; 1980; 64(2-3):247-50. PubMed ID: 7407758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iv methyl-CCNU and ftorafur with or without methanol-extracted residue of BCG for metastatic adenocarcinoma of the colon.
    Diggs CH; Wiernik PH; Smyth AC
    Cancer Treat Rep; 1977 Nov; 61(8):1581-3. PubMed ID: 336200
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II study of melphalan in colorectal carcinoma.
    DiBenedetto J; Moayeri H; Evans JT; Mittelman A
    Cancer Treat Rep; 1978 Sep; 62(9):1401-2. PubMed ID: 688286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.